Adam H Schechter's most recent trade in DaVita Inc was a trade of 348 Common Stock done . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 348 | 4,330 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 248.73 per share. | 12 May 2025 | 6,105 | 98,962 (0%) | 0% | 248.7 | 1,518,497 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 30,469 | 118,651 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.67 per share. | 27 Mar 2025 | 13,584 | 105,067 (0%) | 0% | 231.7 | 3,147,005 | Common Stock |
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 349 | 3,982 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,100 | 33,100 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 10,970 | 26,102 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 244.62 per share. | 11 Feb 2025 | 6,121 | 86,445 (0%) | 0% | 244.6 | 1,497,319 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 2,963 | 89,408 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 2,963 | 23,139 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 1,226 | 88,182 (0%) | 0% | 245.1 | 300,542 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 4,460 | 91,901 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 4,460 | 18,382 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 3,250 | 93,911 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 3,250 | 15,132 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 1,345 | 92,566 (0%) | 0% | 246.3 | 331,233 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 1,240 | 90,661 (0%) | 0% | 247.7 | 307,198 | Common Stock |
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 312 | 3,633 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 243.47 per share. | 11 Nov 2024 | 6,189 | 87,441 (0%) | 0% | 243.5 | 1,506,836 | Common Stock |
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 333 | 3,321 (0%) | 0% | 0 | Common Stock | |
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 363 | 2,988 (0%) | 0% | 0 | Common Stock | |
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 366 | 2,625 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Schechter H. Adam | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 2,964 | 95,277 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam Schechter H. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 2,964 | 54,225 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | H. Schechter Adam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 1,231 | 52,994 (0%) | 0% | 227.5 | 279,991 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 41,400 | 41,400 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 13,380 | 101,491 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Schechter H. Adam | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,250 | 52,410 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | H. Adam Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,250 | 98,241 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | H. Schechter Adam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 1,149 | 51,261 (0%) | 0% | 223.7 | 257,043 | Common Stock |
| Laboratory Corp. Of Americ... | Adam Schechter H. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 3,094 | 88,111 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Schechter H. Adam | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 3,094 | 49,982 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | H. Adam Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 822 | 49,160 (0%) | 0% | 221.5 | 182,106 | Common Stock |
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 529 | 2,259 (0%) | 0% | 0 | Common Stock | |
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 475 | 1,730 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 73,013 | 89,841 | - | - | Restricted Stock Unit | |
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 516 | 1,255 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 42,353 | 65,534 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 18,646 | 46,888 (0%) | 0% | 224.7 | 4,189,756 | Common Stock |
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 658 | 739 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,656 | 24,351 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,656 | 16,828 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 1,170 | 23,181 (0%) | 0% | 248.1 | 290,312 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 27,400 | 27,400 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 8,740 | 19,484 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 3,507 | 10,744 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 3,507 | 23,063 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.50 per share. | 04 Feb 2023 | 1,368 | 21,695 (0%) | 0% | 244.5 | 334,476 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 2,773 | 20,361 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 2,773 | 14,251 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.99 per share. | 02 Feb 2023 | 805 | 19,556 (0%) | 0% | 255.0 | 205,267 | Common Stock |
| DaVita Inc | Adam H. Schechter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 81 | 81 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 2,007 | 18,481 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 2,007 | 17,024 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 222.56 per share. | 01 Nov 2022 | 893 | 17,588 (0%) | 0% | 222.6 | 198,746 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 28,100 | 28,100 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 7,970 | 19,031 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 3,507 | 11,061 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 3,507 | 17,886 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.48 per share. | 04 Feb 2022 | 1,412 | 16,474 (0%) | 0% | 277.5 | 391,802 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 2,773 | 15,182 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 2,773 | 14,568 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.18 per share. | 02 Feb 2022 | 803 | 14,379 (0%) | 0% | 273.2 | 219,364 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 2,007 | 13,295 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 2,007 | 17,341 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 288.78 per share. | 01 Nov 2021 | 886 | 12,409 (0%) | 0% | 288.8 | 255,859 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 3,506 | 19,348 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 3,506 | 12,316 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.78 per share. | 04 Feb 2021 | 1,028 | 11,288 (0%) | 0% | 223.8 | 230,046 | Common Stock |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 29,000 | 29,000 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 8,320 | 22,854 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 2,006 | 14,534 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 2,006 | 9,695 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 207.23 per share. | 02 Nov 2020 | 885 | 8,810 (0%) | 0% | 207.2 | 183,399 | Common Stock |